{"classes":[{"categories":[{"measurements":[{"groupId":"OG001","value":"0"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"OG001","value":"1"}]}],"title":"No"}],"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"}],"units":"Participants"}],"description":"The visual acuity assessment was performed by an ophthalmologist or an optometrist under the guidance of an ophthalmologist. Visual acuity is defined as acuteness or clearness of vision. The number of participants with worsening visual acuity due to cataracts at Week 12 of Part 1 are presented. Change due to cataracts is categorized as \"Yes\" or \"No.\"","groups":[{"description":"In Part 1, participants aged between 6 and 17 years with a body weight \\<27 kg received placebo 37.5 mg QD, and those with a body weight \\>=27 kg received placebo 50 mg QD. Participants of East Asian ancestry received a starting dose of placebo 25 mg QD. Participants aged between 1 and 5 years received placebo 1.2 mg/kg QD; participants of East Asian ancestry received a starting dose of placebo 0.8 mg/kg/day.","id":"OG000","title":"Part 1 (Randomized Period) - Placebo"},{"description":"In Part 1, participants aged between 6 and 17 years with a body weight \\&lt;27 kg received eltrombopag 37.5 mg QD, and those with a body weight \\&gt;=27 kg received eltrombopag 50 mg QD. Participants of East Asian ancestry received a starting dose of eltrombopag 25 mg QD. Participants aged between 1 and 5 years received eltrombopag 1.2 mg/kg QD; participants of East Asian ancestry received a starting dose of eltrombopag 0.8 mg/kg/day.","id":"OG001","title":"Part 1 (Randomized Period) - Eltrombopag"}],"paramType":"NUMBER","populationDescription":"Safety Population. Only those participants who had a result of 'worsening' in assessment of change of visual acuity at this timepoint were analyzed.","reportingStatus":"POSTED","timeFrame":"Baseline and Week 12 of Part 1","title":"Number of Participants With Worsening Visual Acuity Due to Cataracts at Week 12 of Part 1","type":"SECONDARY","unitOfMeasure":"Participants"}